Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Rigshospitalet, Denmark |
---|---|
Information provided by: | Rigshospitalet, Denmark |
ClinicalTrials.gov Identifier: | NCT00256009 |
A randomize trial: expectation or evacuatio uteri for the treatment after late abortion
Condition | Intervention | Phase |
---|---|---|
Abortion, Spontaneous Abortion, Induced |
Drug: Cytotec |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Evacuatio Uteri or Conservtive Treatment After Late Abortion. A Randomize Trial. |
Estimated Enrollment: | 200 |
Estimated Study Completion Date: | January 2009 |
A randomize trial adressing 200 women consecutively recruited from clinical practice at Rigshospitalet.Expectation: administration of 800 microgram Cytotec half an hour after delivery. Surgery: Evacuation of the uterus
Ages Eligible for Study: | 18 Years to 60 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
abortion at gestational age (ultrasound) 14+0 - 20+0
Exclusion Criteria:
Allergy to cytotec
Contact: Lars Alling Møller, Md phd | 0045 35451338 | Lars.Alling@rh.dk |
Principal Investigator: | Lars Alling Møller, MD phd | Rigshospitalet, Denmark |
Study ID Numbers: | KF 01 279545 |
Study First Received: | November 18, 2005 |
Last Updated: | May 31, 2006 |
ClinicalTrials.gov Identifier: | NCT00256009 History of Changes |
Health Authority: | Denmark: National Board of Health |
Late abortion |
Pregnancy Complications Misoprostol Abortion, Spontaneous |
Pregnancy Complications Abortion, Spontaneous |